Obesity is a growing global health problem, the prevalence of which has tripled since 1975. It currently affects 650 million people worldwide, and in Spain the prevalence among adults is 28%. This ...

Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people develop metabolic diseases of this kind. About a quarter of all obese ...

The common forms of type 2 diabetes are caused by a constellation of genetic and epigenetic factors and molecular changes related to diet; lifestyle, including lack of exercise and sleep; ...

New research suggests GLP-1 drug tirzepatide may increase brown fat activity, helping the body burn more calories beyond ...

Aging may trigger the appearance of specialized stem cells that supercharge the body's ability to create new belly fat. The ...

Body composition and obesity-related complications differ between men and women, but incretin-based medications confer benefits among all adults, according to a speaker at the Heart in Diabetes CME ...

Scientists have found a new type of stem cell that may explain why belly fat grows with age—and could lead to new obesity ...

Tirzepatide increased the proportion of participants with detectable brown adipose tissue (BAT) activity from 41.2% at ...

Nobel laureate, Howard Hughes Medical Institute investigator, and neuroscience professor at Scripps, Ardem Patapoutian, PhD, is a co-senior author of the study. Scientists at Scripps Research ...